Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial



Status:Recruiting
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:November 2014
End Date:June 2016
Contact:Principal Investigator, MD, MPH
Email:cti@ppnyc.org
Phone:212-274-7324

Use our guide to learn which trials are right for you!

This study is a blinded randomized trial to compare two different doses and intervals of
buccal misoprostol for cervical preparation before surgical abortion at 13 to 16 weeks'
gestation: 400 mcg administered 3 hours before D&E (dilation and extraction), and 600 mcg
administered 1.5 hours before D&E.

Primary objective: To compare operative times after two different doses and intervals of
misoprostol using a non-inferiority design.

Secondary objectives: To compare the doses and intervals of misoprostol for differences in:
(1) initial cervical dilation; (2) need for mechanical dilation and ease of dilation if
required; (3) ability to complete the abortion procedure without further cervical
preparation; (4) complications; (5) provider variables including ease of procedure and
satisfaction with cervical preparation; (6) patient variables including pre-operative side
effects, post-operative pain, and acceptability


Inclusion Criteria:

- 18 years of age and older

- Eligible for pregnancy termination at Planned Parenthood of NYC

- Able to give informed consent

- English speaking

Exclusion Criteria:

- Reports active bleeding, severe pain, or symptoms of spontaneous labor at enrollment

- Intrauterine fetal demise identified on pre-operative ultrasound

- Allergy to misoprostol
We found this trial at
1
site
?
mi
from
New York, NY
Click here to add this to my saved trials